Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | DM-CHOC-PEN |
| Synonyms | |
| Therapy Description |
DM-CHOC-PEN (4-Demethyl-4-cholesteryloxycarbonylpenclomedine) is a carbonate derivative of 4-demethylpenclomedine that alkylates DNA, resulting in cell death (PMID: 19255760, PMID: 26186448). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| DM-CHOC-PEN | 4-Demethyl-4-cholesteryloxycarbonylpenclomedine | DM-CHOC-PEN (4-Demethyl-4-cholesteryloxycarbonylpenclomedine) is a carbonate derivative of 4-demethylpenclomedine that alkylates DNA, resulting in cell death (PMID: 19255760, PMID: 26186448). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT03371004 | Phase I | DM-CHOC-PEN | DM-CHOC-PEN Plus Radiation for Brain Tumors | Completed | USA | 0 |
| NCT03668847 | Phase II | DM-CHOC-PEN | DM-CHOC-PEN for Brain Tumors in AYA Subjects | Completed | USA | 0 |
| NCT02889445 | Expanded access | DM-CHOC-PEN | A Phase I Trial of DM-CHOC-PEN in Adolescent and Young Adult (AYA) Subjects With Advanced Cancers | No longer available | USA | 0 |